ArticleRMD open2024

Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry.

Jasmin B Kuemmerle-Deschner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.